A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test

ClinicalTrials.gov ID: NCT02790437

Public ClinicalTrials.gov record NCT02790437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test

Study identification

NCT ID: NCT02790437
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Hansa Biopharma AB; Industry
Enrollment: 19 participants

Conditions and interventions

Conditions

Kidney Failure, Chronic

Interventions

IdeS Drug
Kidney transplantation Procedure

Drug · Procedure

Eligibility (public fields only)

Age range: 18 Years to 70 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 31, 2016
Primary completion: Dec 11, 2017
Completion: Jul 2, 2018
Last update posted: May 19, 2021

2016 – 2018

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
Cedars-Sinai Medical Center	Los Angeles	California	90048	—
The Johns Hopkins Hospital	Baltimore	Maryland	21205	—
New York University School of Medicine	New York	New York	10016	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02790437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 19, 2021 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02790437 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →